Wang, Lin http://orcid.org/0000-0002-9370-6891
Xing, Xi
Zeng, Xianfeng
Jackson, S. RaElle
TeSlaa, Tara
Al-Dalahmah, Osama http://orcid.org/0000-0002-3442-5459
Samarah, Laith Z.
Goodwin, Katharine
Yang, Lifeng
McReynolds, Melanie R. http://orcid.org/0000-0001-5427-2739
Li, Xiaoxuan http://orcid.org/0000-0002-7010-955X
Wolff, Jeremy J.
Rabinowitz, Joshua D. http://orcid.org/0000-0002-1247-4727
Davidson, Shawn M. http://orcid.org/0000-0002-3475-0382
Article History
Received: 30 March 2021
Accepted: 13 December 2021
First Online: 7 February 2022
Competing interests
: J.D.R. is a member of the Rutgers Cancer Institute of New Jersey and the University of Pennsylvania Diabetes Research Center; a co-founder and stockholder in Toran, Sofro and Serien Therapeutics; and advisor and stockholder in Agios Pharmaceuticals, Kadmon Pharmaceuticals, Bantam Pharmaceuticals, Colorado Research Partners, Rafael Pharmaceuticals, Barer Institute and L.E.A.F. Pharmaceuticals. S.M.D. is an associate member of Rutgers Cancer Institute of New Jersey. All other authors declare no competing interests.